Celsius / Alani Nu

A $1.65bn cheque for a brand whose main asset is that people already listen to it. This is the cleanest ‘audience’ deal on my list.

What they were really buying

Under 3x revenue is not a premium in this category, and that is the interesting bit. Alani Nu was not sold as a science story or a shelf story. It was sold as a community that happened to have a product attached, built largely by and for women in a segment that energy drinks had spent a decade ignoring.

You cannot put ‘they already trust her’ on a balance sheet. You can, however, put it through your own distribution and watch what happens, which is precisely the plan.

The number I keep looking at

$50m of run-rate cost synergies inside a $1.65bn price. That is a cost deal on its face. But roughly 12x fully synergized EBITDA is doing a lot of quiet work in that sentence, because it prices the target as though the synergies have already happened.

So the honest read is a low revenue multiple paired with an EBITDA multiple that already assumes execution. Two very different pictures of the same cheque, and which one is true gets decided in the warehouse, not the deck.

Where I would push

• An audience brand is only worth the audience’s attention, and attention is rented, not owned.
• $500m of the price is Celsius stock, so the seller is still exposed to Celsius execution.
• Cost synergies are the easy half. Nobody has yet shown the revenue half.

My call

The most defensible price of the five. Under 3x sales for a brand growing into an adjacent segment is not where deals go wrong. The risk is not the number, it is whether Celsius can scale the thing without sanding off the reason anyone cared.

Sources

• Celsius Holdings, acquisition announcement and terms.
• BevNET, structure and multiples.